Sound Processing Changes in Babies With Opioid Exposure
A Comparison of Mismatch Negativity Waveform Differences in Opioid-exposed and Non-exposed Neonates.
A Comparison of Mismatch Negativity Waveform Differences in Opioid-exposed and Non-exposed Neonates.
Sponsor study identifier
observational
37
1 country
1
Study Start
March 25, 2019
Actual (reported)Primary Completion
June 30, 2023
Actual (reported)Study Completion
June 30, 2023
Actual (reported)The purpose of this study is to identify problems with interpreting sounds in babies that have been exposed to opioids prior to birth. Being able to identify these issues in infancy may allow us to find children who may have problems with language learning later in life so that we can try to minimize these.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 30, 2023
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 13, 2018
Actual (reported)June 26, 2018
Actual (reported)March 25, 2019
Actual (reported)June 30, 2023
Actual (reported)June 30, 2023
Actual (reported)Percent with neonates with auditory cortical processing deficiencies
A bone conducting sound playback lead will be placed over a bony prominence on the skull to transmit the auditory oddball paradigm that will be repeatedly played via this lead. The oddball paradigm will consist of a repeating sound loop including multiple identical 5-30 decibels tones of same duration interspersed with single 5-30 decibels tone of different pitch but same duration (deviant tone). Continuous EEG recordings will be collected during playback. EEG tracings will be analyzed specifically for the mismatch negativity waveforms. Comparisons will be made between the deviant and standard responses (sound tones) and the percentage of neonates with no difference between the standard and deviant waveforms will be determined.
baseline
prenatal opioid exposure
no prenatal opioid exposure
Investigators with routine access to infant and maternal records will identify subjects based on review of patient charts upon admission to the NICU or nursery.
University of Rochester Medical Center
Rochester, New York, 14642, United States
Ronnie Guillet, MD, PHD
University of Rochester
37 participants (actual enrollment reported by the registry).
First Submitted
June 13, 2018
First Posted
June 26, 2018
Study Start
March 25, 2019
Actual (reported)tAN to Mitigate Withdrawal Behaviors in Neonates
Contact the study team to confirm eligibility.
Primary Completion
June 30, 2023
Actual (reported)Study Completion
June 30, 2023
Actual (reported)Last Updated
July 20, 2023
Record last verified: 2023-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: